United Kingdom Hypodermic Needles Market Insight
Published: 29 July 2026 | Report Format: Electronic (PDF) | Author: Sanket and Pranali
The United Kingdom Hypodermic Needles Market was valued at USD 0.36 Billion in 2025 and is projected to reach USD 0.61 Billion by 2035, expanding at a CAGR of 5.42% during the forecast period. Market growth is being driven by rising demand for injectable drugs, increasing vaccination programs, the growing prevalence of diabetes requiring insulin administration, expanding surgical procedures, and continuous adoption of safety-engineered hypodermic needles across hospitals, clinics, and home healthcare settings.
United Kingdom Hypodermic Needles Market Forecasts to 2035
- The United Kingdom Hypodermic Needles Market was estimated at USD 0.36 Billion in 2025.
- The market is expected to grow at a CAGR of 5.42% from 2025 to 2035.
- The market is projected to reach approximately USD 0.61 Billion by 2035.
Notable Insights for the United Kingdom Hypodermic Needles Market
- Segmentation Based on Product Type, Safety Hypodermic Needles accounted for the largest market share of approximately 57.4% in 2025, supported by stringent needlestick injury prevention regulations and increasing adoption across NHS hospitals and diagnostic centres.
- Segmentation Based on End User, Hospitals & Clinics represented nearly 61.8% of total market revenue in 2025, driven by high patient admissions, expanding vaccination programs, and increasing volumes of injectable therapies and surgical procedures.
- Becton, Dickinson and Company (BD) reported USD 20.17 Billion in revenue during fiscal 2025, supported by strong global demand for injection devices, safety-engineered hypodermic needles, and medication delivery technologies across healthcare facilities.
- Terumo Corporation generated approximately USD 6.47 Billion in revenue during fiscal 2025, reflecting continued growth in medical consumables, vascular access products, and hypodermic needle solutions supplied to hospitals and healthcare providers worldwide.
Download the eBook (ToC)
Research Methodologies Used to Analyze the United Kingdom Hypodermic Needles Market
This study combines primary and secondary research methodologies to evaluate the United Kingdom Hypodermic Needles Market. Primary research includes interviews with hospital procurement managers, medical device manufacturers, healthcare distributors, clinicians, regulatory specialists, infection prevention experts, and senior industry executives. Secondary research incorporates NHS publications, MHRA guidelines, company annual reports, healthcare journals, trade associations, government healthcare statistics, and commercial market intelligence sources. Market estimates are developed using both top-down and bottom-up approaches, while data triangulation ensures reliable market sizing, competitive benchmarking, and long-term forecasting accuracy.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Hypodermic Needles Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Hypodermic Needles Market
- Becton, Dickinson and Company (BD)
- Terumo Corporation
- Nipro Corporation
- B. Braun SE
- Smiths Medical
- Cardinal Health, Inc.
- Owen Mumford Ltd.
- Hindustan Syringes & Medical Devices Ltd.
- SOL-Millennium Medical Group
- Vogt Medical Vertrieb GmbH.
Recent Developments:
- In September 2025, Becton, Dickinson and Company (BD) introduced an enhanced safety hypodermic needle portfolio featuring improved passive safety technology to strengthen needlestick injury prevention across hospitals and healthcare facilities in the United Kingdom.
- In May 2025, Terumo Corporation collaborated with NHS healthcare providers and clinical specialists to support the adoption of advanced safety injection devices, improving healthcare worker protection and patient safety across multiple clinical settings.
Market Segmentation
United Kingdom Hypodermic Needles Market, By Product Type
- Safety Hypodermic Needles
- Conventional Hypodermic Needles
United Kingdom Hypodermic Needles Market, By Application
- Drug Delivery
- Vaccination
- Blood Collection
- Insulin Administration
- Others
United Kingdom Hypodermic Needles Market, By End User
- Hospitals & Clinics
- Ambulatory Surgical Centres
- Diagnostic Laboratories
- Home Healthcare
- Others
United Kingdom Hypodermic Needles Market, By Distribution Channel
- Direct Sales
- Medical Device Distributors
- Online Medical Suppliers
United Kingdom Hypodermic Needles Market, By Region
- England
- Scotland
- Wales
- Northern Ireland
Expert Views:
The United Kingdom Hypodermic Needles Market is expected to record steady growth through 2035 as demand for injectable medicines, vaccination programs, and chronic disease management continues to increase. Manufacturers are focusing on safer needle technologies, product innovation, and strategic collaborations with healthcare providers to improve clinical efficiency, reduce needlestick injuries, and support long-term market expansion.
Author: Sanket and Pranali By Decisions Advisors and Consulting